Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain

Summary

This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Palmitoylethanolamide (PEA) compared to placebo on menstrual pain in otherwise healthy participants 18 years and over.

Timeline

Start

2023-05-19

Primary completion

2023-12-20

Completion

2023-12-20

Drugs

Indications